Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis

Transplantation Proceedings

Volumn 37, Issue 5, 2005, Pages 2148-2150

  Ersoy, A ^a   Kahvecioglu, S ^a   Ersoy, C ^a   Cift, A ^a   Dilek, K ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; LOSARTAN; PREDNISOLONE;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTOSIS; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; PRIORITY JOURNAL;

ADULT; ANEMIA; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; CALCIUM CHANNEL BLOCKERS; CREATININE; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; LOSARTAN; MALE; POLYCYTHEMIA;

EID: 21844457129     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.03.085     Document Type: Article

References (15)

1. D.V. Vlahakos, K.P. Marathias, B. Agroyannis Posttransplant erythrocytosis Kidney Int 63 2003 1187
2. A. Ersoy, K. Dilek, M. Usta Angiotensin-II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients Clin Transplant 16 2002 202
3. J. Calvino, X.M. Lens, R. Romero Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension Nephrol Dial Transplant 15 2000 82
4. A.E. el-Agroudy, N.A. Hassan, M.A. Foda Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients Am J Nephrol 23 2003 300
5. W. Kim, S. Lee, S.K. Kang Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients Transplant Proc 34 2002 3223
6. R. Holgada, F. Anaya, D. Del Castillo Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation Nephrol Dial Transplant 16 suppl 1 2001 117
7. A.Y. Wang, A.W. Yu, C.W. Lam Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis Am J Kidney Dis 39 2002 600
8. P. Inigo, J.V. Torregrosa, J.M. Campistol Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis Transplant Proc 31 1999 2321
9. D. Ducloux, V. Fournier, C. Bresson-Vautrin Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis Transpl Int 11 1998 312
10. W.K. Tsang, K.L. Tong, H.W. Chan Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis Transplant Proc 30 1998 3072
11. R.J. Klaassen, T. van Gelder, J. Rischen-Vos Losartan, and angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis Transplantation 64 1997 780
12. D.D. Castillo, J.M. Campistol, L. Guirado Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients Kidney Int 54 suppl 68 1998 S135
13. L.F. Morrone, S. Di Paolo, F. Logoluso Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients role of growth factors and cytokines Transplantation 64 1997 913
14. M. Mrug, T. Stopka, B.A. Julian Angiotensin II stimulates proliferation of normal early erythroid progenitors J Clin Invest 199 1997 2310
15. A. Ishikawa, K. Kawabe Beneficial effect of losartan against proteinuria from the renal allograft Transplant Proc 35 2003 289